{"id":"https://openalex.org/W2042831379","doi":"https://doi.org/10.1097/00004850-200103000-00003","title":"Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study","display_name":"Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2042831379","doi":"https://doi.org/10.1097/00004850-200103000-00003","mag":"2042831379","pmid":"https://pubmed.ncbi.nlm.nih.gov/11236073"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200103000-00003","doi":"https://doi.org/10.1097/00004850-200103000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200103000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M. Berk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"M. Berk","raw_affiliation_strings":["Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa. 039berk@chiron.wits.ac.za","Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa","e-mail: [email\u00a0protected]","fax: +011 7172423","to M. Berk, Department of Psychiatry, Witwatersrand University Medical School, 7 York Road, Parktown, 2193, South Africa Tel: +011 7172526"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa. 039berk@chiron.wits.ac.za","institution_ids":["https://openalex.org/I192619145"]},{"raw_affiliation_string":"Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa","institution_ids":["https://openalex.org/I192619145"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +011 7172423","institution_ids":[]},{"raw_affiliation_string":"to M. Berk, Department of Psychiatry, Witwatersrand University Medical School, 7 York Road, Parktown, 2193, South Africa Tel: +011 7172526","institution_ids":["https://openalex.org/I192619145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060652891","display_name":"C. Ichim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"C. Ichim","raw_affiliation_strings":["Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa","institution_ids":["https://openalex.org/I192619145"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113530408","display_name":"Shlomo Brook","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"S. Brook","raw_affiliation_strings":["Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Witwatersrand University Medical School, Parktown, South Africa","institution_ids":["https://openalex.org/I192619145"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I192619145"],"apc_list":null,"apc_paid":null,"fwci":3.8419,"has_fulltext":false,"cited_by_count":104,"citation_normalized_percentile":{"value":0.93036922,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"2","first_page":"87","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6399999856948853},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.5720000267028809},{"id":"https://openalex.org/keywords/5-ht2a-receptor-antagonism","display_name":"5-HT2A receptor antagonism","score":0.8080000281333923},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonism","display_name":"5-HT3 receptor antagonism","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.9587872624397278},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8334988355636597},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.6473744511604309},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.6201357841491699},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.609740674495697},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5671620965003967},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5646620988845825},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.55641770362854},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5078971982002258},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48993462324142456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4530772864818573},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.4508405327796936},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.400066614151001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.381084144115448},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3617590069770813},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.2959233522415161},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.27255499362945557},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07419547438621521},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.05846688151359558},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/00004850-200103000-00003","doi":"https://doi.org/10.1097/00004850-200103000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200103000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:11236073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11236073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:dro.deakin.edu.au:DU:30071308","doi":null,"is_oa":false,"landing_page_url":"http://www.ncbi.nlm.nih.gov/pubmed/11236073","pdf_url":null,"source":{"id":"https://openalex.org/S4306402457","display_name":"Deakin Research Online (Deakin University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I149704539","host_organization_name":"Deakin University","host_organization_lineage":["https://openalex.org/I149704539"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W14678275","https://openalex.org/W1974318817","https://openalex.org/W1976381380","https://openalex.org/W1984470001","https://openalex.org/W2017787186","https://openalex.org/W2017803289","https://openalex.org/W2018524402","https://openalex.org/W2019679310","https://openalex.org/W2026774800","https://openalex.org/W2032544822","https://openalex.org/W2036397846","https://openalex.org/W2041472256","https://openalex.org/W2052250805","https://openalex.org/W2068854599","https://openalex.org/W2075960719","https://openalex.org/W2085146940","https://openalex.org/W2090404564","https://openalex.org/W2093900681","https://openalex.org/W2140606211","https://openalex.org/W2261854704","https://openalex.org/W2321439674","https://openalex.org/W2402363043","https://openalex.org/W2414178995","https://openalex.org/W2438837234"],"related_works":["https://openalex.org/W2001911655","https://openalex.org/W2019299984","https://openalex.org/W2093531845","https://openalex.org/W2164958875","https://openalex.org/W2362339910","https://openalex.org/W2098923701","https://openalex.org/W2368366294","https://openalex.org/W2363664401","https://openalex.org/W4251851710","https://openalex.org/W2062936381"],"abstract_inverted_index":{"The":[0,72,122],"negative":[1,89,160,179],"symptoms":[2,161,180],"of":[3,32,41,53,66,75,102,137,166,181],"schizophrenia":[4],"remain":[5],"a":[6,48,79,172],"major":[7],"clinical":[8,37],"challenge.":[9],"Mirtazapine":[10],"is":[11],"an":[12,164],"antidepressant":[13],"with":[14,69],"antagonist":[15],"properties":[16],"at":[17,99,153],"5-HT2A,":[18],"5-HT3":[19],"and":[20,84,130],"alpha":[21],"2":[22],"receptors":[23],"as":[24,26],"well":[25],"indirect":[27],"5-HT1a":[28],"agonist":[29],"effects.":[30],"Many":[31],"these":[33],"pharmacological":[34],"actions":[35],"have":[36],"or":[38,55],"preclinical":[39],"evidence":[40],"efficacy":[42],"in":[43,63,82,92,133,159,177],"schizophrenia.":[44,71,182],"This":[45],"study":[46],"was":[47,78,142,162],"6-week":[49],"randomized":[50],"placebo-controlled":[51],"trial":[52,77],"mirtzepine":[54],"placebo":[56,98,109],"add":[57],"on":[58,148],"to":[59,97],"haloperidol":[60],"5":[61],"mg":[62],"the":[64,76,93,100,146,149,157,178],"treatment":[65],"30":[67],"patients":[68],"DSM-IV":[70],"primary":[73],"finding":[74],"42%":[80],"reduction":[81],"Positive":[83],"Negative":[85],"Syndrome":[86],"Scale":[87],"(PANSS)":[88],"symptom":[90],"scores":[91],"mirtazapine":[94,138,176],"group":[95],"compared":[96],"end":[101],"6":[103],"weeks":[104],"(mirtazapine":[105],"13.9,":[106],"SD":[107,111],"1.56;":[108,112],"23.9,":[110],"P":[113],"=":[114,117,120],"0.000,":[115],"F":[116],"20.31,":[118],"d.f.":[119],"1).":[121],"PANNS":[123],"total":[124],"scores,":[125],"Clinical":[126],"Global":[127],"Impression":[128],"severity":[129],"improvement":[131,158],"scales":[132],"addition":[134],"showed":[135],"superiority":[136],"over":[139],"placebo.":[140],"There":[141],"no":[143],"difference":[144],"between":[145],"groups":[147],"Hamilton":[150],"depression":[151],"scale":[152],"endpoint,":[154],"suggesting":[155],"that":[156],"not":[163],"artifact":[165],"mood":[167],"improvement.":[168],"These":[169],"results":[170],"suggest":[171],"potential":[173],"role":[174],"for":[175]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}